154 related articles for article (PubMed ID: 21892768)
1. Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis.
Fan R; Chen P; Zhao D; Tong JL; Li J; Liu F
J Mol Histol; 2011 Oct; 42(5):473-81. PubMed ID: 21892768
[TBL] [Abstract][Full Text] [Related]
2. Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis.
Fan RH; Li J; Wu N; Chen PS
World J Gastroenterol; 2011 Aug; 17(29):3420-30. PubMed ID: 21876634
[TBL] [Abstract][Full Text] [Related]
3. Notch1 promotes hepatitis B virus X protein-induced hepatocarcinogenesis via Wnt/β-catenin pathway.
Sun Q; Wang R; Luo J; Wang P; Xiong S; Liu M; Cheng B
Int J Oncol; 2014 Oct; 45(4):1638-48. PubMed ID: 25017705
[TBL] [Abstract][Full Text] [Related]
4. Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.
Zhu B; Sun L; Luo W; Li M; Coy DH; Yu L; Yu W
Oncotarget; 2017 Apr; 8(14):23289-23302. PubMed ID: 28423575
[TBL] [Abstract][Full Text] [Related]
5. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells.
Weijzen S; Rizzo P; Braid M; Vaishnav R; Jonkheer SM; Zlobin A; Osborne BA; Gottipati S; Aster JC; Hahn WC; Rudolf M; Siziopikou K; Kast WM; Miele L
Nat Med; 2002 Sep; 8(9):979-86. PubMed ID: 12185362
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis.
Mittal S; Subramanyam D; Dey D; Kumar RV; Rangarajan A
Mol Cancer; 2009 Dec; 8():128. PubMed ID: 20030805
[TBL] [Abstract][Full Text] [Related]
7. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
8. Deregulated expression of Notch receptors in human hepatocellular carcinoma.
Gao J; Song Z; Chen Y; Xia L; Wang J; Fan R; Du R; Zhang F; Hong L; Song J; Zou X; Xu H; Zheng G; Liu J; Fan D
Dig Liver Dis; 2008 Feb; 40(2):114-21. PubMed ID: 17920003
[TBL] [Abstract][Full Text] [Related]
9. Minimal cooperation between mutant Hras and c-myc or TGFα in the regulation of mouse hepatocyte growth or transformation in vivo.
Stein TJ; Bowden M; Sandgren EP
Liver Int; 2011 Oct; 31(9):1298-305. PubMed ID: 22093452
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H
Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164
[TBL] [Abstract][Full Text] [Related]
11. Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers.
Mittal S; Sharma A; Balaji SA; Gowda MC; Dighe RR; Kumar RV; Rangarajan A
Mol Cancer Ther; 2014 Dec; 13(12):3198-3209. PubMed ID: 25253780
[TBL] [Abstract][Full Text] [Related]
12. Notch1 signaling contributes to the oncogenic effect of HBx on human hepatic cells.
Wang F; Xia X; Wang J; Sun Q; Luo J; Cheng B
Biotechnol Lett; 2013 Jan; 35(1):29-37. PubMed ID: 22986536
[TBL] [Abstract][Full Text] [Related]
13. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
14. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
[TBL] [Abstract][Full Text] [Related]
15. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
16. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
Newell P; Toffanin S; Villanueva A; Chiang DY; Minguez B; Cabellos L; Savic R; Hoshida Y; Lim KH; Melgar-Lesmes P; Yea S; Peix J; Deniz K; Fiel MI; Thung S; Alsinet C; Tovar V; Mazzaferro V; Bruix J; Roayaie S; Schwartz M; Friedman SL; Llovet JM
J Hepatol; 2009 Oct; 51(4):725-33. PubMed ID: 19665249
[TBL] [Abstract][Full Text] [Related]
17. Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells.
Gao J; Dong Y; Zhang B; Xiong Y; Xu W; Cheng Y; Dai M; Yu Z; Xu H; Zheng G
Int J Oncol; 2012 Nov; 41(5):1773-81. PubMed ID: 22922832
[TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
19. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
Jang JY; Lee YS; Jeon YK; Lee K; Jang JJ; Kim CW
Exp Mol Med; 2013 Jan; 45(1):e3. PubMed ID: 23306701
[TBL] [Abstract][Full Text] [Related]
20. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma.
Zhang L; Chen J; Yong J; Qiao L; Xu L; Liu C
J Exp Clin Cancer Res; 2019 Sep; 38(1):384. PubMed ID: 31477177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
